Extracts fromCurcuma zedoariaInhibit Proliferation of Human Breast Cancer Cell MDA-MB-231In Vitro
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extracts fromCurcuma zedoariaInhibit Proliferation of Human Breast Cancer Cell MDA-MB-231In Vitro
Authors
Keywords
-
Journal
Evidence-based Complementary and Alternative Medicine
Volume 2014, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2014-05-06
DOI
10.1155/2014/730678
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Furanodiene, a Natural Product, Inhibits Breast Cancer Growth Bothin vitroandin vivo
- (2012) Zhangfeng Zhong et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- New Insight into the SDF-1/CXCR4 Axis in a Breast Carcinoma Model: Hypoxia-Induced Endothelial SDF-1 and Tumor Cell CXCR4 Are Required for Tumor Cell Intravasation
- (2012) F. Jin et al. MOLECULAR CANCER RESEARCH
- Release of Apoptotic Cytochrome c From Mitochondria by Dimethylarsinous Acid Occurs Through Interaction With Voltage-Dependent Anion Channel In Vitro
- (2012) Hua Naranmandura et al. TOXICOLOGICAL SCIENCES
- The Differences in CXCR4 Protein Expression Are Significant for the Five Molecular Subtypes of Breast Cancer
- (2012) Ming Zhang et al. ULTRASTRUCTURAL PATHOLOGY
- Higher population-based incidence rates of triple-negative breast cancer among young African-American women
- (2011) Kathryn C. Amirikia et al. CANCER
- Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemia
- (2011) Sergej Konoplev et al. CANCER
- Significance of E-cadherin expression in triple-negative breast cancer
- (2010) S Kashiwagi et al. BRITISH JOURNAL OF CANCER
- CXCR4 Signaling Regulates Metastasis of Chemoresistant Melanoma Cells by a Lymphatic Metastatic Niche
- (2010) M. Kim et al. CANCER RESEARCH
- Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
- (2010) N. Ahmed et al. CURRENT CANCER DRUG TARGETS
- Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted Therapies
- (2010) Daniel J. Toft et al. MOLECULAR ENDOCRINOLOGY
- Therapeutic targeting of microenvironmental interactions in leukemia: Mechanisms and approaches
- (2009) Marina Konopleva et al. DRUG RESISTANCE UPDATES
- Complementary and alternative medicine (CAM) and cancer: The kind face of complementary medicine
- (2009) E. Ernst International Journal of Surgery
- A literature review of complementary and alternative medicine use by colorectal cancer patients
- (2009) Maida J. Sewitch et al. Complementary Therapies in Clinical Practice
- Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients
- (2008) Wen-Jin Yin et al. BREAST CANCER RESEARCH AND TREATMENT
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Basal-Like Breast Cancer: A Critical Review
- (2008) Emad A. Rakha et al. JOURNAL OF CLINICAL ONCOLOGY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype
- (2007) B Mahler-Araujo et al. JOURNAL OF CLINICAL PATHOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started